WAVE Life Sciences (WVE) PT Raised to $15 at RBC Capital

October 21, 2024 6:46 AM EDT Send to a Friend
RBC Capital analyst Luca Issi raised the price target on WAVE Life Sciences (NASDAQ: WVE) to $15.00 (from $7.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login